Measuring the Impact of a Multimodal Intervention on Falls and Fear Falls Among People 65 Years Old, Residents at Home (KitPA)

Measuring the Impact of a Multimodal Intervention on Falls and Fear Falls among People 65 Years Old, Residents at Home in Boulogne city

Study Overview

• Status: Completed
• Conditions: Fall; Old Age; Atrophy
• Intervention / Treatment: Behavioral: fall prevention

Detailed Description

We hypothesize that participation in the multimodal program " Autonomy Prevention Kit " would lead to a decrease in falls and the fear of falling.

this study targets retired people, 65 years of age and over, living at home, identified as being independent (Iso Group Resources type 4-5-6 without formal validation being carried out) but who represent statistically an increased risk of falls in comparison to the general population.

The inclusion takes place before the first session of the Equilibr'Age® workshop. Subjects will have already benefited from a first collective information organized by the Boulogne City Council (see annexes of the CRF). 3 times mark the collection of data.

At the time of inclusion, at the end of the 12 sessions of the Equilbr'Age® workshop (M3) and 3 months after the end of the workshop ( 6 months after the beginning of inclusion).

The study does not involve new acts since it is only an assessment of the effects of a protocol that proposes non-sports activities as well as advice to citizens of the municipality.

• Study Type: Observational
• Enrollment (Actual): 71

Contacts and Locations

Study Locations

• France
  • Ile De France
    • Paris, Ile De France, France, 92100
      • Gérond'if

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Autonomous elderly people walking

Description

Inclusion Criteria:

• Retired
• Age ≥ 65 years;
• GIR ≥ 4
• Commitment to participate in all interventions of the "autonomy prevention" Kit
• Autonomous in its travels
• The person expressed no objection to participating in the KitPA study.

Exclusion Criteria:

• In professional activity
• Age < 65 years;
• GIR < 4
• Person under guardianship or curatorship

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Only
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Comparison of the number of falls before/after and the fear of falling before/after according Equilibr'Age® workshop	Equilibr'Age® workshop	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Comparison of life quality before/after according EQ-ED scale	Quality of life scale	6 months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Assesssment of health status according Self Perceived Health (SPH) scale	Self Perceived Health (SPH) scale	6 months
Assessment of the impacte of workshops according Likert scale		6 months

Collaborators and Investigators

• Sponsor: Gérond'if
• Investigators: Principal Investigator: Frederic Nicolas, master, Gérond'if

Study record dates

Study Major Dates

• Study Start (Actual): May 6, 2019
• Primary Completion (Actual): October 3, 2020
• Study Completion (Actual): December 8, 2022

Study Registration Dates

• First Submitted: February 20, 2019
• First Submitted That Met QC Criteria: May 27, 2019
• First Posted (Actual): May 30, 2019

Study Record Updates

• Last Update Posted (Estimate): January 13, 2023
• Last Update Submitted That Met QC Criteria: January 12, 2023
• Last Verified: January 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathological Conditions, Anatomical; Atrophy
• Other Study ID Numbers: 2018-A02910-55

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No